# Conventional and Non-Conventional Dysplasias Associated with Inflammatory Bowel Disease—A Single-Centre Experience

**Authors:** Anita Sejben, Zsófia Balajthy, Zsófia Krisztina Török, Szintia Almási, Tamás Lantos

PMC · DOI: 10.3390/medsci14010078 · Medical Sciences · 2026-02-10

## TL;DR

This study examines different types of dysplasias in inflammatory bowel disease patients and finds non-conventional dysplasias are common and require careful evaluation.

## Contribution

The study identifies and characterizes non-conventional dysplasias in IBD patients, emphasizing their prevalence and clinical implications.

## Key findings

- Non-conventional dysplasias were found in 28% of IBD patients with neoplastic lesions.
- Age and male gender were associated with conventional dysplasia, while colorectal carcinoma and M stage were linked to lower odds.
- Macroscopic appearance, localization, and histological subtype showed significant associations with dysplasia types.

## Abstract

Background: Recent studies have identified multiple subtypes of non-conventional dysplastic lesions associated with inflammatory bowel disease (IBD). This study aimed to characterise and compare all IBD-associated dysplasias and determine their prevalence within a Southern Hungarian population. Methods: A consecutive cohort of IBD patients between 2011 and 2023 was retrospectively analysed. All available hyper- or neoplastic samples were reclassified according to current pathological criteria. Results: In this 13-year retrospective, single-centre, cohort study, 2396 IBD patients were identified, with 176 possessing samples for re-evaluation. Conventional dysplasia was identified in 130 patients (74%), non-conventional dysplasia in 50 patients (28%), and 33 patients were diagnosed with both (19%). Age (OR = 1.06; 95% CI: [1.03–1.09]; p < 0.001) and male gender (OR = 2.63; 95% CI: [1.07–6.45]; p = 0.032) were associated with higher odds of conventional dysplasia, compared with non-conventional dysplasia. Colorectal carcinoma development and M stage were associated with lower odds of conventional dysplasia: OR = 0.17 ([0.06–0.47]; p < 0.001) and OR = 0.05 ([0.01–0.5]; p = 0.006), respectively. Significant associations were observed with macroscopic appearance (p = 0.013), grade (p = 0.002), localisation (p < 0.001), size (p = 0.016), macroscopic morphology (p = 0.004), grade (p < 0.001), histological subtype (p = 0.001), T stage (p = 0.008) and microsatellite status (p = 0.019). Conclusions: Non-conventional dysplasias were identified in a substantial proportion of neoplastic lesions (50/176; 28%) among IBD patients. These findings highlight the importance of thorough histopathological evaluation to confirm complete resection. Patients with IBD-associated dysplasia, particularly non-conventional types, may benefit from intensified surveillance strategies.

## Linked entities

- **Diseases:** inflammatory bowel disease (MONDO:0005265), colorectal carcinoma (MONDO:0024331)

## Full-text entities

- **Genes:** TENM1 (teneurin transmembrane protein 1) [NCBI Gene 10178] {aka ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1}
- **Diseases:** PSC (MESH:D015209), aneuploidy (MESH:D000782), CCD (MESH:D002292), UC (MESH:D003093), U (MESH:C536925), colonic adenomas (MESH:D003108), dysplastic (MESH:D004416), signet ring cell carcinoma (MESH:D018279), carcinogenesis (MESH:D063646), Neoplastic lesions (MESH:D009062), GCD (MESH:D002276), TAs (MESH:D000236), IBD (MESH:D015212), SSL (MESH:D009059), VAs (MESH:D018253), SSL-like dysplasia (MESH:C537675), adenomatous dysplasia (MESH:D011125), MMR deficiency (MESH:C536928), Tumour (MESH:D009369), colitis (MESH:D003092), adenocarcinoma (MESH:D000230), gastrointestinal diseases (MESH:D005767), mucinous (MESH:D002288), CD (MESH:D003424), Conventional dysplasia (MESH:C563514), Dysplasias (MESH:D015792), CRC (MESH:D015179), polypoid dysplasias (MESH:D000092342), DPD (MESH:D054067), NOS (MESH:C536665), metastases (MESH:D009362), serrated epithelial change (MESH:D009375), inflammation (MESH:D007249), injury to (MESH:D014947)
- **Chemicals:** eosin (MESH:D004801), haematoxylin (MESH:D006416), HE (MESH:D006371), TVAs (-)
- **Species:** gut metagenome (species) [taxon 749906], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922047/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922047/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922047/full.md

---
Source: https://tomesphere.com/paper/PMC12922047